Plavix finds role in atrial fibrillation
This article was originally published in Scrip
Executive Summary
Adding Sanofi-Aventis/Bristol-Myers Squibb's oral platelet inhibitor Plavix (clopidogrel) to aspirin therapy can reduce the risk of cardiovascular events including stroke in patients with atrial fibrillation who are unable to take warfarin, data from the ACTIVE-A study show.